NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2018, Vol. 30 ›› Issue (5): 847-855.doi: 10.16333/j.1001-6880.2018.5.019

• Article • Previous Articles     Next Articles

Effects of Isoliquiritigenin on Proliferation,Apoptosis and NF-κB Signaling Pathway in Human Lung Cancer H460 Cells

QIN Yue-mu1,2, JIANG Ze-qun1,2, MA Yan-xia2, ZHANG Xu1,2*   

  1. 1School of Medicine and Life Sciences,Nanjing University of Chinese Medicine; 2Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor,Nanjing University of Chinese Medicine,Nanjing 210023,China
  • Online:2018-06-04 Published:2018-06-04

Abstract: To study the effect of Isoliquiritigenin (ISL) on the proliferation,cell cycle and apoptosis of human lung cancer cell line NCI-H460,and to explore its relevant molecular mechanism to provide a new scientific basis for lung cancer treatment.NCI-H460 cells in logarithm growth phase were selected and cultured with different concentration of ISL.The cell viability was detected by CCK-8 assay,while cell cycle and cell apoptosis were measured by cytometry assay.The mRNA expression of lung cancer related genes in NCI-H460 cells were determined by PCR array.The protein levels of p-p65,IκB α、IκB β Bax and Bcl-2 were detected by Western blot analysis.Then,the effect of ISL on the expression of NF-κB p65 was observed by immunofluorescence assay.The results showed that ISL could inhibit proliferation and induce cell cycle block,as well as cell apoptosis in NCI-H460 cells.The mechanism may be related with the inhibition of the NF-κB signaling pathway,by inhibiting the entry of NF-κB p65 into the nucleus,it failing to exert its transcriptional activity and ultimately affecting the expression of downstream apoptotic proteins Bax and Bcl-2.

Key words: isoliquiritigenin, lung cancer, NCI-H460, cell apoptosis, NF-κB

CLC Number: